Autolus Therapeutics Ltd reported $493.23M in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
AstraZeneca USD 115.83B 1.82B Jun/2026
Autolus Therapeutics Ltd USD 493.23M 33.84M Jun/2026
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Novartis USD 122.03B 3.5B Jun/2026
Roche Holding CHF 98.2B 2.5B Jun/2026
Silence Therapeutics USD 131.44M 15.35M Dec/2025